{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:47:41Z","timestamp":1783813661993,"version":"3.55.0"},"reference-count":32,"publisher":"Microbiology Society","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"abstract":"<jats:p>\n                  <jats:bold>Purpose.<\/jats:bold> Serological analysis is an essential tool for the diagnosis of pertussis or whooping cough, disease surveillance and the evaluation of vaccine effectiveness against <jats:italic>\n                     <jats:named-content content-type=\"species\">\n                        <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/doi.org\/10.1601\/nm.1747\" xlink:type=\"simple\">Bordetella pertussis<\/jats:ext-link>\n                     <\/jats:named-content>\n                  <\/jats:italic>. Accurate measurement of anti-pertussis toxin (anti-PT) IgG antibody levels in sera is essential. These measurements are usually performed using immunological methods such as ELISA and multiplex immunoassays. However, there are a large number of different assay systems available, and therefore standardization and harmonization between the methods are needed to obtain comparable data.<\/jats:p>\n               <jats:p>\n                  <jats:bold>Methodology.<\/jats:bold> In collaboration with ECDC, the EUPert-LabNet network has organized three External Quality Assessment (EQA) schemes (2010, 2012 and 2016), which initially identified the diverse range of techniques and reagents being used throughout Europe. This manuscript discusses the findings of each of the EQA rounds and their impact on the participating laboratories.<\/jats:p>\n               <jats:p>\n                  <jats:bold>Results.<\/jats:bold> The studies have shown an increasing number of laboratories (from 65% to 92%) using only the recommended coating antigen, purified PT, in immunoassays, as this allows exact quantification of serum anti-PT IgG and since PT is only produced by <jats:italic>\n                     <jats:named-content content-type=\"species\">\n                        <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/doi.org\/10.1601\/nm.1747\" xlink:type=\"simple\">Bordetella pertussis<\/jats:ext-link>\n                     <\/jats:named-content>\n                  <\/jats:italic> this prevents cross-reactivity with other species. There has also been an increase in the numbers of laboratories (from 59% to 92%), including a WHO reference serum in their assays, which allows anti-PT IgG concentrations to be measured in International Units, thus enabling the comparison of results from different methods and laboratories. In addition, manufacturers have also considered these recommendations when they produce commercial ELISA kits.<\/jats:p>\n               <jats:p>\n                  <jats:bold>Conclusion.<\/jats:bold> The three EQA rounds have resulted in greater harmonization in methods among different laboratories, showing a significant improvement of the ELISA methods used for serodiagnosis of pertussis.<\/jats:p>","DOI":"10.1099\/jmm.0.000926","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T16:27:00Z","timestamp":1555432020000},"page":"741-747","source":"Crossref","is-referenced-by-count":14,"title":["Improvement in serological diagnosis of pertussis by external quality assessment"],"prefix":"10.1099","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-5182","authenticated-orcid":false,"given":"Kevin","family":"Markey","sequence":"first","affiliation":[{"name":"Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Douglas-Bardsley","sequence":"additional","affiliation":[{"name":"Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Asokanathan","sequence":"additional","affiliation":[{"name":"Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4862-6507","authenticated-orcid":false,"given":"Norman K.","family":"Fry","sequence":"additional","affiliation":[{"name":"Immunisation and Countermeasures Division, Public Health England - National Infection Service, 61 Colindale Avenue, London NW9 5EQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-1580","authenticated-orcid":false,"given":"Alex-Mikael","family":"Barkoff","sequence":"additional","affiliation":[{"name":"University of Turku, Institute of Biomedicine, Department of Microbiology, Virology and Immunology, Kiinamyllynkatu 10, 20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6575-3439","authenticated-orcid":false,"given":"Sabrina","family":"Bacci","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control (ECDC), Gustav III:s boulevard 40, 16973 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-6753","authenticated-orcid":false,"given":"Csaba","family":"K\u00f6dm\u00f6n","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control (ECDC), Gustav III:s boulevard 40, 16973 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[{"name":"University of Turku, Institute of Biomedicine, Department of Microbiology, Virology and Immunology, Kiinamyllynkatu 10, 20520 Turku, Finland"},{"name":"Department of Medical Microbiology, Capital Medical University, No.10 Xi Tou Tiao, You'an Men Wai, Feng Tai District, 100069 Beijing, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3235"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765201520140663"},{"key":"R3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00430-017-0524-z","article-title":"Bordetella pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance","volume":"207","author":"Dorji","year":"2018","journal-title":"Med Microbiol Immunol"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00083-15"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.05.029"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2011.07.005"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-15"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-1104-y"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2008.02.018"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftv050"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.32.20239-en"},{"key":"R12","article-title":"External quality assurance scheme for Bordetella pertussis serology 2013","year":"2014"},{"key":"R13","article-title":"EUVAC-NET","year":"2017"},{"key":"R14","article-title":"Homepage","year":"2017"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.7.3.422-426.2000"},{"key":"R16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/cdli.3.6.689-700.1996","article-title":"Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens","volume":"3","author":"Lynn","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.96.6.A48","article-title":"Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines","volume":"96","author":"Meade","year":"1995","journal-title":"Pediatrics"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.072"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1007\/PL00015016"},{"key":"R20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"de Melker","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268804003401"},{"key":"R22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268817001108","article-title":"Pertussis diagnosis in Belgium: results of the National reference centre for Bordetella anno 2015","volume":"145","author":"Martini","year":"2017","journal-title":"Epidemiol Infect"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268804003012"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.6973"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01371-10"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.11.006"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268804003206"},{"key":"R28","volume-title":"Guidance and Protocol for the Serological Diagnosis of Human Infection with Bordetella pertussis","year":"2012"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00372-08"},{"key":"R30","article-title":"International collaborative study: evaluation of proposed International Standard for pertussis antiserum (human)","author":"Xing","year":"2008","journal-title":"World Health Organization, Expert Committee onBiological Standardization WHO\/BS\/08 2083"},{"key":"R31","article-title":"External quality assurance scheme for Bordetella pertussis serology 2016","year":"2018"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1759-7"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.000926?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:46:51Z","timestamp":1702669611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.000926","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}